Standard Biotools (LAB) Profit After Tax (2010 - 2026)

Standard Biotools (LAB) has 17 years of Profit After Tax data on file, last reported at $127.1 million in Q1 2026.

• On a quarterly basis, Profit After Tax rose 643.72% year-over-year to $127.1 million in Q1 2026; TTM through Mar 2026 was $97.3 million, a 178.96% increase from a year earlier, with the FY2025 full-year figure at -$58.8 million, up 35.31% from the prior year.
• Profit After Tax for Q1 2026 stood at $127.1 million, up from $35.4 million in the prior quarter.
• Over the last five years, Profit After Tax for LAB reached as high as $127.1 million in Q1 2026 and fell as low as -$76.3 million in Q1 2022.
• Historically, Profit After Tax has averaged -$15.8 million across 5 years, with a median of -$26.9 million in 2024.
• Across the five-year window, Profit After Tax sank 305.33% in 2022 and jumped 643.72% in 2026, its largest moves.
• Year by year, Profit After Tax stood at -$20.8 million in 2022, then soared by 264.76% to $34.3 million in 2023, then sank by 179.12% to -$27.2 million in 2024, then surged by 230.1% to $35.4 million in 2025, then soared by 259.43% to $127.1 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were $127.1 million in Q1 2026, $35.4 million in Q4 2025, and -$31.7 million in Q3 2025.